Filter
991
Text search:
Price,
R.
Featured
Recommendations
87
New Publications
242
Language
Document type
No document type
505
Studies & Reports
265
Guidelines
125
Manuals
40
Strategic & Response Plan
23
Fact sheets
14
Training Material
10
Situation Updates
3
Resource Platforms
3
Brochures
1
Infographics
1
Online Courses
1
Countries / Regions
Global
51
South Africa
28
India
27
Nepal
19
Ethiopia
16
Uganda
16
Kenya
16
Ukraine
16
Western and Central Europe
16
Sierra Leone
14
Liberia
14
Africa
14
Congo, Democratic Republic of
13
Philippines
11
Zambia
11
Bangladesh
11
Myanmar / Burma
11
Nigeria
10
Syria
10
Ghana
9
South Sudan
9
Cambodia
9
Sudan
9
Latin America and the Carribbean
9
Afghanistan
8
Tanzania
8
Rwanda
8
Mozambique
8
Brazil
8
South–East Asia Region
8
Eastern Europe
8
Malawi
7
Zimbabwe
6
Venezuela
6
Russia
6
Guinea
5
Germany
5
Namibia
5
Middle East and North Africa
5
Cameroon
4
Haiti
4
Benin
4
Botswana
4
Lesotho
4
East and Southern Africa
4
Eastern Europe and Central Asia
4
Asia
4
Albania
4
Tajikistan
4
North America
4
Jamaica
4
USA
3
Somalia
3
Pakistan
3
Turkey
3
China
3
Indonesia
3
Angola
3
Sri Lanka
3
West and Central Africa
3
Kyrgyzstan
3
Vietnam
3
Portugal
3
Spain
3
Burkina Faso
2
Senegal
2
Chad
2
Thailand
2
Central African Republic
2
Eswatini/ Swaziland
2
North Macedonia
2
Colombia
2
Madagascar
2
Yemen
2
Paraguay
2
Southern Africa
2
Kazakhstan
2
Turkmenistan
2
United Kingdom
2
Bosnia and Herzegovina
2
Mali
1
Côte d’Ivoire / Ivory Coast
1
Jordan
1
Egypt
1
Papua New Guinea
1
Argentina
1
Peru
1
Serbia
1
Ecuador
1
Bhutan
1
North Korea
1
Timor Leste/ East Timor
1
Estonia
1
Lithuania
1
Moldova
1
Japan
1
Denmark
1
France
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
294
Clinical Guidelines
106
Public Health
65
Women & Child Health
38
Key Resources
37
Pharmacy & Technologies
19
Capacity Building
5
Toolboxes
Mental Health
104
HIV
90
COVID-19
77
Planetary Health
74
TB
38
Conflict
37
Pharmacy
34
NCDs
33
Global Health Education
31
AMR
28
Disability
22
Health Financing Toolbox
22
Ebola
16
Natural Hazards
16
Refugee
13
Caregiver
13
NTDs
13
Rapid Response
11
Social Ethics
9
Specific Hazards
3
Cholera
2
Zika
2
Polio
1
South Sudan
1
Typhoon
1
The UNAIDS 2020 global report is a call to action. It highlights the scale of the HIV epidemic and how it runs along the fault lines of inequalities.
UNAIDS report on the global AIDS epidemic shows that 2020 targets will not be met because of deeply unequal success; COVID-19 risks blowing HIV progress way off course. Missed targets have resulted in 3.5 million more HIV infections and 820 000 more AIDS-related deaths since 2015 than if the world w
...
Contributions in International Seminars 1988 -2008
Intercultural Pastoral Care and Counselling, no. 20
Le présent document est une mise à jour du document d’information scientifique publié le 29 mars 2020 intitulé Modes of transmission of virus causing COVID-19: implications for infection prevention and control (IPC) precaution recommendations et comprend les nouvelles don
...
6 July 2021. Three new nucleic acid amplification test (NAAT) classes are endorsed by WHO and included.
The latest operational handbook includes the new classes recommended by WHO. It aims at facilitating the implementation of the WHO recommendations by the Member States, technical partners, and ot
...
The primary audience of these recommendations includes healthcare providers who are responsible for developing national and local health protocols (particularly those related to hypertensive disorders of pregnancy), and those directly providing care to pregnant women and their newborns, including mi
...
Key Considerations
This brief focuses on cross-border movement in Eastern and Southern Africa (ESA) and its implications for development of risk communication and community engagement (RCCE) strategies aimed at preventing transmission of COVID-19 in the ESA region. Given the extensive risk of cross
...
The Millennium Development Goals (MDGs) showed
that global commitment and collective action
could significantly reduce the disease burdens of
three deadly communicable diseases: HIV/AIDS,
tuberculosis (TB) and malaria. The MDGs helped
focus efforts on these three deadly diseases
and leveraged
...
India is experiencing rapid demographic and epidemiological transitions with NCDs causing significant disability, morbidity and mortality both in urban and rural populations and across all socioeconomic strata. According to the ICMR State Level Disease Burden Initiative, in 2016, NCDs accounted to a
...
Organizing and Delivering High Quality Care for Chronic Noncommunicable Diseases in the Americas
This paper aims to provide aid agencies with initial analysis and guidance to inform the design, implementation and adaptation of conflict-sensitive humanitarian and development responses to the COVID-19 pandemic. It presents a series of overarching considerations to take into account when determini
...
Web annex 6: Injectable prostaglandins versus
placebo or no treatment
Evidence to Decision Framework
Web annex 5: Oxytocin and ergometrine versus placebo or no treatment
Evidence to decision framework
Web annex 2: Carbetocin versus placebo or no treatment
Evidence to decision framework
The COVID-19 pandemic has exacerbated and added yet another layer of vulnerability to an already dire web of vulnerabilities of girls in the African continent, which constitute about 49% of the total child population. Critically, gender equality and girls’ multidimensional vulnerability have been
...
Sepsis remains a leading cause of mortality and morbidity, especially during the first five days of life and in low and middle-income countries (LMIC) [1]. Hospital infection also remains a major cause of mortality in children despite progress encountered in the last decades.
Available in Arabic, Chinese, English, French, Portuguese and Spanish
https://apps.who.int/iris/handle/10665/334254
Interim guidance, 6 October 2021
Direct detection of SARS-CoV-2 viral proteins (antigens) in nasal swabs and other respiratory secretions using lateral flow immunoassays (also known as rapid diagnostic tests, RDTs) offers a faster and less expensive method to test for SARS-CoV-2 than the reference
...
